Ideawise Technologies Private Limited

Business Overview

• Operates as "Lifechart" / "Lifechart Ayurveda" — an Ayurveda-based digital wellness and healthtech platform founded in 2021-2022 by Mukul Shah (CEO), Mansi Shah/Sharma, Chief Business Officer, and K Sandeep (CTO).
• Lifechart began as an online consultation platform connecting patients to Ayurvedic doctors for chronic conditions, stress, hypertension, sleep disorders, gut issues, and sells herbal syrups/teas D2C via lifechartayurveda.in, Shopify storefront.
• In 2024 it launched "Guttify," India's first diagnosis-led gut-health brand combining at-home diagnostics, pH-based saliva acidity test, planned Rs 99 kits, with Ayurveda-backed products, targeting India's ~$18B gut-wellness market.
• DPIIT-recognised startup.
• Sources: StartupTalky, YourStory, Entrackr, eHealth Magazine, TheCompanyCheck, Outlook India.

Sector & Classification

Sector classified variously as "Computer and related activities" (Tofler), "Internet and Online Healthcare Services" (TheCompanyCheck), and "Professional, scientific and technical activities" (TheCompanyCheck principal activity) — sources disagree on NIC bucket; operationally the company runs healthtech/D2C wellness brands

Directors & Key Management

GST Registrations

Primary GSTIN: 07AAGCI2036R1Z7 (Masters India) — state code 07 = Delhi, consistent with registered office; registered ~7 Sept 2021; status Active; Regular taxpayer; PAN embedded = AAGCI2036R. Only one GSTIN identified (Delhi); no evidence of multi-state registrations found. Single-source confirmation (Masters India only) — partial.

Financials

• FY2025, year ended 31 Mar 2025: Revenue ~Rs 1.28 Cr, reported down ~2% YoY, TheCompanyCheck
• EBITDA/PAT figures locked behind paywall on both Tofler and TheCompanyCheck.
• Tofler additionally reports (as of Mar 2025) Net Profit Margin 7.03%, Return on Equity 7.53%, Debt-to-Equity 0.18 — implying a small positive PAT, ~Rs 9 lakh order of magnitude if margin applies to the ~Rs1.28Cr revenue, not independently confirmed.
• Standalone vs consolidated basis not stated by either source.
• Filed Annual Returns/Financial Statements up to 31 Mar 2024 per one InstaFinancials-derived summary.
• Overall: partial, single-source per data point, no full P&L available without paid subscription.

Funding History

• Two rounds reported: (1) Oct 2024 seed round, ~$500K, led by Prajay Advisors, Unichem Laboratories founders' family office, $250K, with Agility Ventures, Expert Dojo, Sunn91 Ventures, government seed schemes, and angels Nitish Mittersain, Nazara Technologies, Ahana Gautam (Open Secret), Sarath Sura, Marwari Angels, Entrackr, BioSpectrum India. (2) May 2025 extended seed round, $360K, co-led by Prajay Advisors and new investor Unichem Labs, same angel base, Entrackr, eHealth Magazine, BW Disrupt, Indian Startup Times.
• Cumulative funding reported as "over $1 million." Multiple consistent trade-press sources, Entrackr, eHealth Magazine, BioSpectrum India, BW Disrupt, — confirmed for round existence/amounts
• No valuation disclosed.

Shareholding

• Not obtained — no source disclosed a cap table or shareholding percentages. Founders Mukul Shah and Mansi Shah are the named directors and presumed promoter-shareholders
• Institutional/angel investors named above hold stakes from the two funding rounds but percentages not disclosed anywhere found.

Related Parties

• Group/brand structure: Ideawise Technologies Pvt Ltd is the corporate entity
• It operates the "Lifechart" / "Lifechart Ayurveda" consumer brand and its sub-brand "Guttify." No separate group holding company or other related-party entities identified.
• Caution: a same-named "IdeaWise" digital marketing/branding agency (ideawise.in) was found during research but its business description, logo design, SEO, social media marketing, does not match this healthtech company — likely an unrelated same-named entity, NOT used as this company's domain/logo to avoid entity confusion.

Credit Ratings

• Not obtained — no CRISIL/ICRA/CARE rating found for this company; expected for a small pre-Series-A startup with no registered charges/borrowings requiring a bank rating.

Competitive Landscape

• India gut-health / microbiome-wellness space: The Good Bug, CosMix Wellness, Veera Health, BugSpeaks, microbiome-based nutraceuticals/personalised probiotics, Leucine Rich Bio, Peping, all early-stage/seed-scale, similar to Guttify.
• Broader Ayurveda-wellness D2C peers for the Lifechart consultation+products model: Kapiva, Baidyanath, Dabur's digital Ayurveda initiatives, Patanjali, large/legacy scale, much bigger than Ideawise.
• Sources: YourStory, gut-health-startups trend piece, Outlook India, general market knowledge — named peers are seed/early-stage scale except Dabur/Patanjali which are large legacy FMCG players.

Frequently Asked Questions